Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Barriuso

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Frontiers in Endocrinology|June 24, 2021
The Impact of <sup>68</sup>Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine TumoursDaniel J Cuthbertson, Jorge Barriuso, Angela Lamarca, et al.
Frontiers in Microbiology|February 27, 2026
Integrating electroactive microorganisms into active soil management strategiesLenon Romano Modesto, Ignacio Baquedano, Ezgi Öğün Ramalhete, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2024
Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma PeritoneiJordi Martínez-Quintanilla, Débora Cabot, Doménico Sabia, et al.
Neuroendocrinology|January 28, 2021
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU StudyPaula Jimenez-Fonseca, Alberto Carmona-Bayonas, Angela Lamarca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2019
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU StudyAlberto Carmona-Bayonas, Paula Jiménez-Fonseca, Ángela Lamarca, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitorsEvert S M van Aken, Ajeet Kumar Gandhi, Sean M O'Cathail, et al.
Molecular Biology and Evolution|November 19, 2020
Genomic Analysis Enlightens Agaricales Lifestyle Evolution and Increasing Peroxidase DiversityFrancisco J Ruiz-Dueñas, José M Barrasa, Marisol Sánchez-García, et al.
JAMA Network Open|February 28, 2024
Serum Tumor Markers and Outcomes in Patients With Appendiceal AdenocarcinomaAbdelrahman Yousef, Mahmoud Yousef, Mohammad A Zeineddine, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Frontiers in Endocrinology|June 24, 2021
The Impact of <sup>68</sup>Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine TumoursDaniel J Cuthbertson, Jorge Barriuso, Angela Lamarca, et al.
Frontiers in Microbiology|February 27, 2026
Integrating electroactive microorganisms into active soil management strategiesLenon Romano Modesto, Ignacio Baquedano, Ezgi Öğün Ramalhete, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2024
Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma PeritoneiJordi Martínez-Quintanilla, Débora Cabot, Doménico Sabia, et al.
Neuroendocrinology|January 28, 2021
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU StudyPaula Jimenez-Fonseca, Alberto Carmona-Bayonas, Angela Lamarca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2019
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU StudyAlberto Carmona-Bayonas, Paula Jiménez-Fonseca, Ángela Lamarca, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitorsEvert S M van Aken, Ajeet Kumar Gandhi, Sean M O'Cathail, et al.
Molecular Biology and Evolution|November 19, 2020
Genomic Analysis Enlightens Agaricales Lifestyle Evolution and Increasing Peroxidase DiversityFrancisco J Ruiz-Dueñas, José M Barrasa, Marisol Sánchez-García, et al.
JAMA Network Open|February 28, 2024
Serum Tumor Markers and Outcomes in Patients With Appendiceal AdenocarcinomaAbdelrahman Yousef, Mahmoud Yousef, Mohammad A Zeineddine, et al.
Pageof 14